Hypoxia Patterns in Primary and Metastatic Prostate Cancer Environments

Area of Science:

• Oncology
• Cancer Biology
• Medical Imaging

Background:

• Metastatic prostate cancer (PCa) remains a leading cause of cancer mortality.
• Hypoxia is recognized as a significant factor contributing to PCa aggressiveness and progression.
• Understanding the role of hypoxia in the metastatic cascade is critical for developing effective treatments.

Purpose of the Study:

• To characterize hypoxia patterns in primary and metastatic prostate cancer environments using a novel dual reporter imaging system.
• To investigate the temporal evolution of hypoxia-inducible factor (HIF) activity in vivo.
• To gain insights into the role of hypoxia in prostate cancer metastasis.

Main Methods:

• Development and application of a dual reporter imaging strategy in human PCa PC-3 cells, utilizing long-lived EGFP and short-lived luciferase reporters under hypoxia response element (HRE) control.
• Constitutive expression of tdTomato for in vivo cancer cell detection.
• In vivo and ex vivo imaging of subcutaneous (nonmetastatic) and orthotopic (metastatic) PC-3 tumors in a human PCa xenograft model.

Main Results:

• Distinct patterns of EGFP and luciferase expression were observed in subcutaneous, orthotopic, and metastatic PC-3 tumors.
• The dual reporter system successfully visualized differential hypoxia levels and temporal dynamics in primary and metastatic sites.
• New insights into the presence and role of hypoxia in prostate cancer metastasis were obtained.

Conclusions:

• The dual HIF reporter system provides valuable information on hypoxia dynamics in primary and metastatic prostate cancer.
• Distinct hypoxia patterns are present in different tumor microenvironments, influencing prostate cancer progression.
• Targeting hypoxia pathways may represent a promising therapeutic strategy for metastatic prostate cancer.